Australia's largest stock trading and investment forum Australia's #1 stock forum

CGS

Click for more information

0.00%

$1.24 cogstate ltd

Good news, page-9

First 9 Last

Share
Profile

Follow
tomhagen

253 Posts.

72

07/07/23

11:14

Post #: 68670337
Share

Originally posted by jellyroll ↑

Excellent news, the label approved by the FDA was just about as broad as could have been hoped for and now CMS coverage follows.

So many doors now open in the AD sector, starting with Donanemab and many other therapeutics working their way through the pipeline. We then also have registration trials, optimisation trials, trials for reformulations, trials for easier delivery methods (subcutaneous), combination trials and all the while as we get better at treatment we need to be able to triage those in the community on to formal diagnostic pathways and treatment. All in all plenty of demand for Cogstate to capture and no one better placed in the AD space.

All of this also improves the chance of takeover talks resuming

Expand

Great news. CMS have followed up already. Will reimburse if the physician submits data to a registry. https://www.cms.gov/newsroom/press-...-available-following-fda-traditional-approval

CGS Price at posting: $1.65 Sentiment: None Disclosure: Held
1 Upvote

1 Great analysis

Reply

There are more pages in this discussion • 1 more message in this thread...

First 9 Last

Add CGS (ASX) to my watchlist

(20min delay)
Last $1.24		Change 0.000(0.00%)		Mkt cap ! $212.5M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	8	$1.25

Sellers (Offers)

Price($)	Vol.	No.
$1.30	1322	1

View Market Depth

No.	Vol.	Price($)
1	8	1.250
1	3	1.245
1	3	1.240
1	2	1.235
1	5	1.230

Price($)	Vol.	No.
1.300	1322	1
1.345	4000	1
1.350	2000	1
1.390	10000	1
1.400	5000	1

Last trade - 10.02am 27/05/2024 (20 minute delay)

CGS (ASX) Chart

Day chart unavailable